...
首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population.
【24h】

A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population.

机译:乌干达人群中两种紧急避孕药方案的随机临床试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Recent trials on emergency contraception (EC) have indicated that levonorgestrel (LNG) used alone has fewer side-effects and is more efficacious than the Yuzpe regimen (high dose combined oral contraceptive pills). However, the experienced side-effects and acceptability may vary between different groups or societies. OBJECTIVE: The primary objective of this study was to determine side-effects and acceptability of two emergency contraceptive pill (ECP) regimens among users in Kampala, Uganda. STUDY DESIGN: Randomized clinical trial. METHODS: A total of 337 women were enrolled in a double blind randomized clinical trial. Women requesting ECPs within 72 hours after unprotected sexual intercourse received either LNG or the Yuzpe regimen. The women returned for follow-up after three days and a follow-up interview was performed after one year. RESULTS: Levonorgestrel had significantly fewer side-effects than the Yuzpe regimen (p < 0.001). There was a significant association between having worries about the method and experiencing side-effects (p < 0.001). Most women (81%) were prime users of EC. The majority would recommend ECP to other clients. CONCLUSIONS: Levonorgestrel is a superior option to the Yuzpe regimen and should be promoted as the recommended ECP. Having worries about ECP may influence experience of the side-effects. Correct information is critical in promotion of ECP use.
机译:背景:近期关于紧急避孕(EC)的试验表明,单独使用左炔诺孕酮(LNG)的副作用较小,并且比Yuzpe疗法(高剂量联合口服避孕药)更有效。但是,不同群体或社会之间经历的副作用和可接受性可能有所不同。目的:本研究的主要目的是确定乌干达坎帕拉使用者中两种紧急避孕药(ECP)方案的副作用和可接受性。研究设计:随机临床试验。方法:共有337名妇女参加了一项双盲随机临床试验。在无保护的性交后72小时内要求ECP的妇女接受LNG或Yuzpe疗法。这些妇女三天后返回接受随访,一年后进行了一次随访。结果:左炔诺孕酮的副作用明显少于Yuzpe方案(p <0.001)。对方法的担忧与出现副作用之间存在显着关联(p <0.001)。大多数女性(81%)是EC的主要使用者。大多数人会向其他客户推荐ECP。结论:左炔诺孕酮是优斯佩方案的较好选择,应推广为推荐的ECP。担心ECP可能会影响副作用的体验。正确的信息对于促进ECP的使用至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号